Koers PsyBio Therapeutics Corp. Toronto S.E.
Aandelen
PSYB
CA5263612098
Biotechnologie & Medisch Onderzoek
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 2,87 mln. 3,93 mln. 2,69 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -11 mln. -15,05 mln. -10,3 mln. | Nettowinst (verlies) 2022 | -4 mln. -5,47 mln. -3,75 mln. | EV/omzet 2021 | - |
Nettoliquiditeiten 2021 | 3,81 mln. 5,21 mln. 3,56 mln. | Nettoschuld 2022 | 135K 184K 126K | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-1,54
x | K/w-verhouding 2022 |
-0,59
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 61,68% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,45% | 122 mld. | |
+21,96% | 116 mld. | |
+24,28% | 27,03 mld. | |
-20,05% | 20,36 mld. | |
-17,35% | 16,43 mld. | |
-16,28% | 15,91 mld. | |
-44,35% | 15,6 mld. | |
+63,91% | 14,94 mld. | |
+2,52% | 13,59 mld. |